Goldcorp (NYSE:GG) declared a monthly dividend on Tuesday, June 10th. Investors of record on Thursday, June 19th will be given a dividend of 0.05 per share on Friday, June 27th. Goldcorp Inc. (USA) (NYSE:GG) net profit margin is -72.10% and weekly performance is 7.69%. On last trading day company shares ended up $25.07. Analysts mean target price for the company is $30.04. Goldcorp Inc. (USA) (NYSE:GG) distance from 50-day simple moving average is 3.12%.
Malbex Resources Inc. (“Malbex”) (TSX VENTURE:MBG) provided an update on its previously announced agreement with Barrick Gold Corporation (USA) (NYSE:ABX) relating to Malbex’s Del Carmen project in San Juan Province, Argentina (the “Del Carmen Project”) whereby Barrick will have the option to earn in to a 51%, and then a 75%, interest in the Del Carmen Project based on meeting certain expenditure requirements. Barrick Gold Corporation (USA) (NYSE:ABX) shares advanced 1.89% in last trading session and ended the day on $16.75. ABX Gross Margin is 39.30% and its return on assets is -28.70%. Barrick Gold Corporation (USA) (NYSE:ABX) quarterly performance is -19.16%.
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) announced the acquisition of Genia Technologies, Inc. (Genia), a privately held company, based in Mountain View, California, USA. Genia is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore technology. Under the terms of the agreement, Roche will pay Genia’s shareholders USD 125 million in cash. In addition to this payment from Roche, Genia’s shareholders may receive up to USD 225 million in contingent payments depending on the achievement of certain milestones. Genia’s proprietary technology is expected to reduce the price of sequencing while increasing speed and sensitivity. Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) shares moved down -0.61% in last trading session and was closed at $37.37, while trading in range of $37.32-$37.50.
Analysts at SunTrust raised their price objective on shares of Becton, Dickinson and (NYSE:BDX) from $128.00 to $138.00 in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the stock. Becton, Dickinson and Co. (NYSE:BDX) ended the last trading day at $118.20. Company weekly volatility is calculated as 0.99% and price to cash ratio as 8.70. Becton, Dickinson and Co. (NYSE:BDX) showed a negative weekly performance of -0.48%.
On May 20, 2014 Unilife Corporation (NASDAQ: UNIS) Industry surveys and reports estimate that the overall global injectable drug delivery systems market will grow at a compound annual growth rate (CAGR) of approximately 11% through 2019, at which time the market will be valued at nearly $19 billion. Unilife Corp (NASDAQ:UNIS) weekly performance is -1.39%. On last trading day company shares ended up $2.83. Analysts mean target price for the company is $8.00. Unilife Corp (NASDAQ:UNIS) distance from 50-day simple moving average is -10.93%.
Leave a Reply